Harsanyi Zsolt — SEC Form 4 filings
SEC reporting owner CIK 1380184. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-28 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | Director | 5 | — | — | 10 |
| Emergent BioSolutions Inc. (EBS) | Chairman, Director | 3 | — | — | 6 |
Form 4 filings — Harsanyi Zsolt
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 25,344 @ $0 · Grant/award (A): 11,296 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Aptevo Therapeutics Inc. (APVO) | Grant/award (A): 7,200 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 34,403 @ $0 · Grant/award (A): 15,824 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | Aptevo Therapeutics Inc. (APVO) | Grant/award (A): 925 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 7 · Option exercise (M): 81 · Option exercise (M): 7 (derivative) @ $0 · Option exercise (M): 81 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 17,430 @ $0 · Grant/award (A): 25,748 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1380184 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →